Abcam to acquire Epitomics International - MarketLine Financial Deals

Abcam to acquire Epitomics International

Abcam to acquire Epitomics International - MarketLine Financial Deals
Abcam to acquire Epitomics International
Published Mar 05, 2012
2 pages — Published Mar 05, 2012
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Abcam plc, a UK-based antibodies and reagents supplier, has entered into a definitive agreement to acquire the entire issued share capital of Epitomics International, Inc.

  
Source:
Document ID
MA100935_120306
Country
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Abcam to acquire Epitomics International" Mar 05, 2012. Alacra Store. Dec 06, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Abcam-to-acquire-Epitomics-International-2052-78563>
  
APA:
MarketLine Financial Deals. (2012). Abcam to acquire Epitomics International Mar 05, 2012. New York, NY: Alacra Store. Retrieved Dec 06, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Abcam-to-acquire-Epitomics-International-2052-78563>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.